• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病中的铁代谢紊乱与贫血

Disorders of Iron Metabolism and Anemia in Chronic Kidney Disease.

作者信息

Panwar Bhupesh, Gutiérrez Orlando M

机构信息

Department of Medicine, University of Alabama at Birmingham, Birmingham, AL.

Department of Medicine, University of Alabama at Birmingham, Birmingham, AL; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL.

出版信息

Semin Nephrol. 2016 Jul;36(4):252-61. doi: 10.1016/j.semnephrol.2016.05.002.

DOI:10.1016/j.semnephrol.2016.05.002
PMID:27475656
Abstract

Dysregulated iron homeostasis plays a central role in the development of anemia of chronic kidney disease (CKD) and is a major contributor toward resistance to treatment with erythropoiesis-stimulating agents. Understanding the underlying pathophysiology requires an in-depth understanding of normal iron physiology and regulation. Recent discoveries in the field of iron biology have greatly improved our understanding of the hormonal regulation of iron trafficking in human beings and how its alterations lead to the development of anemia of CKD. In addition, emerging evidence has suggested that iron homeostasis interacts with bone and mineral metabolism on multiple levels, opening up new avenues of investigation into the genesis of disordered iron metabolism in CKD. Building on recent advances in our understanding of normal iron physiology and abnormalities in iron homeostasis in CKD, this review characterizes how anemia related to disordered iron metabolism develops in the setting of CKD. In addition, this review explores our emerging recognition of the connections between iron homeostasis and mineral metabolism and their implications for the management of altered iron status and anemia of CKD.

摘要

铁稳态失调在慢性肾脏病(CKD)所致贫血的发生发展中起核心作用,并且是促红细胞生成素治疗抵抗的主要原因。要理解其潜在的病理生理学,需要深入了解正常的铁生理学和调节机制。铁生物学领域的最新发现极大地增进了我们对人体铁转运激素调节的理解,以及其改变如何导致CKD贫血的发生。此外,新出现的证据表明,铁稳态在多个层面与骨和矿物质代谢相互作用,为研究CKD中铁代谢紊乱的发生机制开辟了新途径。基于我们对正常铁生理学以及CKD中铁稳态异常的最新认识进展,本综述阐述了在CKD背景下与铁代谢紊乱相关的贫血是如何发生的。此外,本综述探讨了我们对铁稳态与矿物质代谢之间联系的新认识,以及它们对CKD中铁状态改变和贫血管理的意义。

相似文献

1
Disorders of Iron Metabolism and Anemia in Chronic Kidney Disease.慢性肾脏病中的铁代谢紊乱与贫血
Semin Nephrol. 2016 Jul;36(4):252-61. doi: 10.1016/j.semnephrol.2016.05.002.
2
Iron Balance and the Role of Hepcidin in Chronic Kidney Disease.铁平衡与铁调素在慢性肾脏病中的作用
Semin Nephrol. 2016 Mar;36(2):87-93. doi: 10.1016/j.semnephrol.2016.02.001.
3
Bone marrow iron distribution, hepcidin, and ferroportin expression in renal anemia.肾性贫血中的骨髓铁分布、铁调素及铁转运蛋白表达
Hematology. 2015 Oct;20(9):543-52. doi: 10.1179/1607845415Y.0000000004. Epub 2015 Mar 8.
4
The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia.成纤维细胞生长因子 23 在炎症和贫血中的作用。
Int J Mol Sci. 2019 Aug 27;20(17):4195. doi: 10.3390/ijms20174195.
5
Targeting the hepcidin-ferroportin pathway in anaemia of chronic kidney disease.针对慢性肾脏病贫血中铁调素-亚铁转运蛋白通路的治疗。
Br J Clin Pharmacol. 2019 May;85(5):935-948. doi: 10.1111/bcp.13877. Epub 2019 Mar 4.
6
Role of Hepcidin-25 in Chronic Kidney Disease: Anemia and Beyond.铁调素-25在慢性肾脏病中的作用:贫血及其他。
Curr Med Chem. 2017;24(14):1417-1452. doi: 10.2174/0929867324666170316120538.
7
Iron homeostasis: transport, metabolism, and regulation.铁稳态:转运、代谢与调节
Curr Opin Clin Nutr Metab Care. 2016 Jul;19(4):276-81. doi: 10.1097/MCO.0000000000000285.
8
Diagnosis of Iron-Deficiency Anemia in Chronic Kidney Disease.慢性肾脏病中铁缺乏性贫血的诊断
Semin Nephrol. 2016 Mar;36(2):94-8. doi: 10.1016/j.semnephrol.2016.02.002.
9
Hepcidin in chronic kidney disease anemia.慢性肾脏病贫血中的铁调素
Vitam Horm. 2019;110:243-264. doi: 10.1016/bs.vh.2019.01.012. Epub 2019 Feb 6.
10
Whole-body iron transport and metabolism: Mechanistic, multi-scale model to improve treatment of anemia in chronic kidney disease.全身铁转运和代谢:改善慢性肾脏病贫血治疗的机制、多尺度模型。
PLoS Comput Biol. 2018 Apr 16;14(4):e1006060. doi: 10.1371/journal.pcbi.1006060. eCollection 2018 Apr.

引用本文的文献

1
The role of ferroptosis in acute kidney injury: the preemptive mode of cell death and the bridging effect.铁死亡在急性肾损伤中的作用:细胞死亡的先发模式及桥梁效应。
Ren Fail. 2025 Dec;47(1):2536732. doi: 10.1080/0886022X.2025.2536732. Epub 2025 Aug 29.
2
AI-Driven Prediction of Renal Stone Recurrence Following ECIRS: A Machine Learning Approach to Postoperative Risk Stratification Incorporating 24-Hour Urine Data.ECIRS术后肾结石复发的人工智能驱动预测:一种结合24小时尿液数据的术后风险分层机器学习方法。
J Clin Med. 2025 Jun 7;14(12):4037. doi: 10.3390/jcm14124037.
3
Iron and ferroptosis in kidney disease: molecular and metabolic mechanisms.
铁与肾脏疾病中的铁死亡:分子与代谢机制
Front Immunol. 2025 Feb 5;16:1531577. doi: 10.3389/fimmu.2025.1531577. eCollection 2025.
4
Desidustat: a novel PHD inhibitor for the treatment of CKD-induced anemia.地西司他:一种用于治疗慢性肾脏病所致贫血的新型脯氨酰羟化酶抑制剂。
Front Nephrol. 2024 Oct 22;4:1459425. doi: 10.3389/fneph.2024.1459425. eCollection 2024.
5
MOF-Based Platform for Kidney Diseases: Advances, Challenges, and Prospects.用于肾脏疾病的基于金属有机框架的平台:进展、挑战与前景
Pharmaceutics. 2024 Jun 11;16(6):793. doi: 10.3390/pharmaceutics16060793.
6
Sleep disorders in chronic kidney disease.慢性肾脏病中的睡眠障碍。
Nat Rev Nephrol. 2024 Oct;20(10):690-700. doi: 10.1038/s41581-024-00848-8. Epub 2024 May 24.
7
Iron Metabolism and Inflammatory Mediators in Patients with Renal Dysfunction.肾功能不全患者的铁代谢与炎症介质。
Int J Mol Sci. 2024 Mar 27;25(7):3745. doi: 10.3390/ijms25073745.
8
Ferroptosis: A New Mechanism in Diabetic Cardiomyopathy.铁死亡:糖尿病心肌病的一种新机制。
Int J Med Sci. 2024 Jan 21;21(4):612-622. doi: 10.7150/ijms.88476. eCollection 2024.
9
Anemia and frailty in the aging population: implications of dietary fiber intake (findings of the US NHANES from 2007-2018).人口老龄化中的贫血与虚弱:膳食纤维摄入的影响(来自 2007-2018 年美国 NHANES 的发现)。
BMC Geriatr. 2023 Oct 7;23(1):634. doi: 10.1186/s12877-023-04352-9.
10
The efficacy and safety of roxadustat for anemia in patients with dialysis-dependent chronic kidney disease: a systematic review and meta-analysis.罗沙司他治疗透析依赖性慢性肾脏病患者贫血的疗效和安全性:系统评价和荟萃分析。
Ren Fail. 2023 Dec;45(1):2195011. doi: 10.1080/0886022X.2023.2195011.